PHIHDL: A Novel HDL Index Predicting Baseline Pulmonary Hemodynamics and Long-Term Survival in PAH
- 1Sigmund Freud Private University Vienna, Faculty of Medicine, Vienna, Austria
Abstract
RationalePulmonary hypertension is defined by pulmonary hemodynamics, but diagnostic and prognostic biomarkers remain limited. Nuclear magnetic resonance (NMR) spectroscopy provides detailed insights, particularly in the lipid metabolism.
ObjectivesTo explore circulating NMR-derived metabolites and lipoprotein-related parameters for their association with pulmonary hemodynamics and to analyse their prognostic properties in pulmonary arterial hypertension (PAH).
MethodsRetrospective analysis of a PAH cohort with complete diagnostic workup including right heart catheterization and baseline serum samples, from the prospective GRaz Pulmonary Hypertension-Metabolism (GRAPH-M) registry.
MeasurementsNMR-derived metabolites and lipoprotein-related parameters were analyzed for their association with clinically relevant parameters of PAH. We defined PHIHDL, a score derived from high-density lipoprotein (HDL) related measures based on their strong association with pulmonary hemodynamics, and evaluated its prognostic value.
ResultsWe included 100 patients with PAH treated at the PH clinic of LKH University Hospital, Medical University of Graz, between 2011 and 2021. Age was 61{+/-}15 years, female/male ratio 2.5, BMI 26{+/-}7 kg/m2, mPAP 41{+/-}16 mmHg, PAWP 8.8{+/-}3.2 mmHg, PVR 8.0{+/-}4.9 WU, and median survival was 8.0 years. During follow-up, 46 patients died. We identified a cluster of 12 HDL-related measures that showed significant inverse association to pulmonary hemodynamics and derived PHIHDL from the reversed scaled average of these particles. PHIHDL was associated with all-cause mortality after adjustment for age and sex (HR 2.96, 95% CI 1.52-5.70), independent of the clinical risk scores COMPERA 2.0 and REVEAL Lite 2.
ConclusionPHIHDL, a pulmonary hemodynamics-based metabolomic score, provides independent prognostic information beyond established risk scores in PAH.
Related
- Predicting the Timing of Adolescent Drinking Onset from Baseline Clinical Data: A Stacked-Encoder Survival Framework with Embedding-Derived Biotypes
- Multiscale hemodynamics model for the pulmonary arteries, arterioles, capillaries, venules and veins
- Temporal and therapeutic confounders in predicting efficacy of immunotherapy rechallenge via baseline intratumoral tertiary lymphoid structures.
- Predicting One-Year CPAP Adherence and Use Trajectories Utilizing Baseline and Early Use Data
- Baseline Tumor Transcriptional Features and Event-Free Survival After Anti-CD19 CAR T-Cell Therapy with Axicabtagene Ciloleucel in Large B-Cell Lymphoma: An Exploratory Reanalysis of the Randomized ZUMA-7 Trial
BibTeX
@misc{pritz2026phihdl,
title = {{PHIHDL: A Novel HDL Index Predicting Baseline Pulmonary Hemodynamics and Long-Term Survival in PAH}},
author = {S. Pritz and N. Bordag and V. Foris and V. Biasin and H. Billensteiner and H. Habisch and T. Madl and G. Marsche and C. Nagaraj and S. Suessner and G. Kovacs and G. Heresi and U. Bodenhofer and H. Olschewski and A. Olschewski},
howpublished = {medRxiv},
year = {2026},
month = aug,
doi = {10.64898/2026.08.31.26361587},
url = {https://www.medrxiv.org/content/10.64898/2026.08.31.26361587v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - PHIHDL: A Novel HDL Index Predicting Baseline Pulmonary Hemodynamics and Long-Term Survival in PAH
AU - S. Pritz
AU - N. Bordag
AU - V. Foris
AU - V. Biasin
AU - H. Billensteiner
AU - H. Habisch
AU - T. Madl
AU - G. Marsche
AU - C. Nagaraj
AU - S. Suessner
AU - G. Kovacs
AU - G. Heresi
AU - U. Bodenhofer
AU - H. Olschewski
AU - A. Olschewski
PY - 2026
DA - 2026/08/31
PB - medRxiv
DO - 10.64898/2026.08.31.26361587
UR - https://www.medrxiv.org/content/10.64898/2026.08.31.26361587v1
AB - RationalePulmonary hypertension is defined by pulmonary hemodynamics, but diagnostic and prognostic biomarkers remain limited. Nuclear magnetic resonance (NMR) spectroscopy provides detailed insights, particularly in the lipid metabolism. ObjectivesTo explore circulating NMR-derived metabolites and lipoprotein-related parameters for their association with pulmonary hemodynamics and to analyse their prognostic properties in pulmonary arterial hypertension (PAH). MethodsRetrospective analysis of a PAH cohort with complete diagnostic workup including right heart catheterization and baseline serum samples, from the prospective GRaz Pulmonary Hypertension-Metabolism (GRAPH-M) registry. MeasurementsNMR-derived metabolites and lipoprotein-related parameters were analyzed for their association with clinically relevant parameters of PAH. We defined PHIHDL, a score derived from high-density lipoprotein (HDL) related measures based on their strong association with pulmonary hemodynamics, and evaluated its prognostic value. ResultsWe included 100 patients with PAH treated at the PH clinic of LKH University Hospital, Medical University of Graz, between 2011 and 2021. Age was 61{+/-}15 years, female/male ratio 2.5, BMI 26{+/-}7 kg/m2, mPAP 41{+/-}16 mmHg, PAWP 8.8{+/-}3.2 mmHg, PVR 8.0{+/-}4.9 WU, and median survival was 8.0 years. During follow-up, 46 patients died. We identified a cluster of 12 HDL-related measures that showed significant inverse association to pulmonary hemodynamics and derived PHIHDL from the reversed scaled average of these particles. PHIHDL was associated with all-cause mortality after adjustment for age and sex (HR 2.96, 95% CI 1.52-5.70), independent of the clinical risk scores COMPERA 2.0 and REVEAL Lite 2. ConclusionPHIHDL, a pulmonary hemodynamics-based metabolomic score, provides independent prognostic information beyond established risk scores in PAH.
ER -